Delivery Order SPE2DX22D0049-SPE2D825FA7PT

The U.S. Defense Department's Medical Supply Chain division awarded a delivery order valued at $10,330.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, competitively awarded delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime vendor vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

AmerisourceBergen Drug Corp serves as a critical federal medical procurement vendor, particularly for Defense Health Agency and other military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering pharmaceuticals across multiple therapeutic domains, including specialty medications, generic and brand-name drugs, vaccines, and medical devices. The company's demonstrated competency in open competition, combined with its substantial prime vendor agreements, positions it as a key supplier for the Defense Department's pharmaceutical and medical supply requirements across global military healthcare operations.